EncrypGen

EncrypGen (DNA) is a cryptocurrency launched in 2017. It anchors a decentralized science project that sits squarely at the intersection of genomic data and blockchain-based incentives.

The platform proposes to dismantle the walled gardens of consumer genetics firms and institutional biobanks. An individual uploads an encrypted genomic sequence through the protocol, then selectively grants researchers query access without ever surrendering custody of the raw data. The DNA token lubricates this exchange, directly addressing the market friction of compensated, privacy-preserving data sharing in human genomics.

EncrypGen operates on the Ethereum network, leaning on its battle-tested virtual machine to enforce permissioned access logic. Smart contracts mediate every transaction, releasing access to aggregated genetic insights only after the requisite DNA tokens have been escrowed. Because it exists as an ERC-20 token rather than a standalone chain, the project inherits Ethereum’s consensus and finality.

The DNA token adheres to the ERC-20 standard, giving it immediate compatibility with the sprawling infrastructure of decentralized exchanges and non-custodial wallets. Its on-chain footprint resolves to contract address 0xef6344de1f…, and every transfer, approval, or data-payment event remains verifiable on Etherscan. Block times, gas dynamics, and throughput mirror Ethereum mainnet, which has hosted the asset since its genesis block in November 2017.

The Gene-Chain whitepaper preceded the token generation event, sketching a peer-to-peer marketplace for hereditary information just as the ICO era reached its zenith. No single founder dominates the public record; instead, a diffuse group of developers and early adopters coalesced through the r/encrypgen subreddit. The project’s American roots and 2017 vintage situate it among the early wave of tokens that sought to bind health data to economic primitives.

The long-term mission reaches beyond simple monetization, aiming instead to rewire the power imbalance around personal genetic material. By storing DNA off-chain with cryptographic fingerprints anchored to Ethereum, EncrypGen envisions a world where every individual functions as a sovereign curator of their own heredity, free from the gravitational pull of corporate silos. That posture carves out a substrate for ethical biomedical research that is distinct from the extractive models of the past.

Mechanically, DNA acts as the settlement and access token inside the Gene-Chain marketplace. An academic lab or AI developer who wishes to interrogate genotype-phenotype correlations must pay in DNA tokens, and the protocol simultaneously distributes those tokens to the wallet addresses of the participants whose profiles informed the result. The token does not govern protocol parameters, yet its velocity serves as a real-time pulse of scientific demand on the network.

Pharmaceutical sponsors and academic consortia holding DNA can commission multi-omic studies by posting token-denominated bounties, with consenting data providers receiving payment only after verifiable genome files land on the network. A person who sequences their exome and uploads it to the EncrypGen marketplace accumulates DNA tokens each time their data contributes to a paid query. Those tokens remain freely tradable or can be set aside to purchase deeper health analytics from the platform itself.

EncrypGen has a maximum supply of 70,938,084.47 tokens. Currently, 0 are in circulation. With a market capitalization of $0, EncrypGen (DNA) ranks #5,682 among all cryptocurrencies.